and Voltaren:
Voltaren (Novartis)
Voltaren was the NSAID we smashed out of the park in the Bodyguard double blind trial. Glyn mentioned that they've now come to OBJ for possible product development. I think that is huge that our product was able to beat the competition to the point that they'd rather join us than fight us. Big tick!
http://hotcopper.com.au/threads/ade...tation.2782068/?post_id=17916837#.V5hU-_l95xA
- Forums
- ASX - By Stock
- WFL
- Ann: Shareholder Update June Quarter 2016-OBJ.AX
Ann: Shareholder Update June Quarter 2016-OBJ.AX, page-38
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online